Year Founded
1988
Ownership
Private
Employees
~100
Stage
Commercial
Modalities
Protein therapeuticsSmall molecule

Jamp Pharma General Information

Canadian pharmaceutical company focused on generic drugs, biosimilars, and natural health products. Recently launched Ipratropium HFA and Jamteki (ustekinumab biosimilar). Acquired manufacturing facility in Lévis, Quebec.

Contact Information

Website
Primary Industry
Pharma
Corporate Office
Boucherville, Quebec
Canada

Drug Pipeline

ipratropium
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Jamp Pharma's pipeline data

Book a demo

Key Partnerships

Alvotech

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Jamp Pharma Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Jamp Pharma's complete valuation and funding history, request access »